Orthopedic Devices are used to treat the disorders and injuries of the musculoskeletal system of human body. Orthobiologics are biomaterials used in orthopedic surgery as an adjunct to faster fusion and healing of the bone. Bone Grafts and Substitutes are used in surgical interventions of bones in the human body under two cases: either when there is a breakage in the bone or in the case of a void between or in the bones due to a number of factors such as age and degenerative diseases. GlobalData uses proprietary data and analytics to provide a comprehensive report on the bone grafts and substitutes devices market, including market shares of different players within Poland. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the bone grafts and substitutes market in Poland was Medtronic followed by Stryker, Bioventus, Globus Medical and Zimmer Biomet.
Bone Graft Substitutes are synthetic substances which are an alternative to Bone Allografts and Autografts. These includes Allograft Bone Chips, Bone Morphogenetic Proteins (BMP), Demineralized Bone Matrix (DBM), Synthetic Bone Substitutes, and Cell-Based Matrices. They are applied across various areas such as trauma for fractures; -CMF for cranio maxillofacial (excluding dental); spinal fusions (since all spinal fusions will need some amount of bone graft usage), and joint reconstruction and replacements (including repairs) for large joints which includes hip and knee, and other joints which include shoulder, elbow, wrist, digit and ankle. Allograft Bone Chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species. Bone Morphogenetic Proteins (BMPs) are low molecular weight, non-collagenous glycoproteins. The Cell-Based Matrices products are a new type of bone substitutes that was introduced to the US market in mid to late 2000s. Demineralized Bone Matrix (DBM) is a form of highly processed allograft bone consisting of collagens, non-collagenous proteins, BMPs and other growth factors that bestow it with both osteoconductive and osteoinductive properties. Synthetic Bone Graft Substitutes are used as substitutes to autograft and allograft bone.
The value of the bone grafts and substitutes devices market within Poland was expected to be over $7m in 2023.
For the latest complete market share analysis of bone grafts and substitutes device market in Poland, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
